Emanuele Cencini

1.9k total citations
55 papers, 535 citations indexed

About

Emanuele Cencini is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Emanuele Cencini has authored 55 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pathology and Forensic Medicine, 30 papers in Genetics and 21 papers in Oncology. Recurrent topics in Emanuele Cencini's work include Lymphoma Diagnosis and Treatment (37 papers), Chronic Lymphocytic Leukemia Research (29 papers) and Viral-associated cancers and disorders (13 papers). Emanuele Cencini is often cited by papers focused on Lymphoma Diagnosis and Treatment (37 papers), Chronic Lymphocytic Leukemia Research (29 papers) and Viral-associated cancers and disorders (13 papers). Emanuele Cencini collaborates with scholars based in Italy, United Kingdom and Switzerland. Emanuele Cencini's co-authors include Monica Bocchia, Alberto Fabbri, Alessandro Gozzetti, Francesco Forconi, Anna Sicuranza, Donatella Raspadori, Francesco Lauria, Elisa Sozzi, Gianluca Gaïdano and Valter Gattei and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Emanuele Cencini

50 papers receiving 532 citations

Peers

Emanuele Cencini
Yuh Shan Lee Singapore
Emanuele Cencini
Citations per year, relative to Emanuele Cencini Emanuele Cencini (= 1×) peers Yuh Shan Lee

Countries citing papers authored by Emanuele Cencini

Since Specialization
Citations

This map shows the geographic impact of Emanuele Cencini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuele Cencini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuele Cencini more than expected).

Fields of papers citing papers by Emanuele Cencini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuele Cencini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuele Cencini. The network helps show where Emanuele Cencini may publish in the future.

Co-authorship network of co-authors of Emanuele Cencini

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuele Cencini. A scholar is included among the top collaborators of Emanuele Cencini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuele Cencini. Emanuele Cencini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zilioli, Vittorio Ruggero, Emanuele Cencini, Sonya De Lorenzo, et al.. (2024). Real‐life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience. Hematological Oncology. 42(3). e3273–e3273.
2.
Perrone, Gabriele, Luigi Rigacci, Giandomenico Roviello, et al.. (2024). Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients. Cancer Drug Resistance. 7. 21–21. 1 indexed citations
3.
Sicuranza, Anna, Elisabetta Abruzzese, Valentina Giai, et al.. (2023). Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26+ leukemia stem cells. Frontiers in Pharmacology. 14. 1194712–1194712. 9 indexed citations
4.
Cencini, Emanuele, Anna Sicuranza, Alberto Fabbri, et al.. (2023). The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study. Leukemia & lymphoma. 64(10). 1634–1642. 3 indexed citations
5.
Cencini, Emanuele, et al.. (2023). Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications. Current Oncology. 30(7). 6111–6133. 17 indexed citations
6.
Cencini, Emanuele, Ilaria Romano, Lara Mannelli, et al.. (2023). Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network). Annals of Hematology. 102(4). 841–849. 1 indexed citations
7.
Cencini, Emanuele, et al.. (2021). Role of lenalidomide in the treatment of peripheral T-cell non-Hodgkin lymphomas. World Journal of Clinical Oncology. 12(10). 882–896. 1 indexed citations
8.
Merli, Michele, Irene Defrancesco, Carlo Visco, et al.. (2020). Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphoma. Leukemia & lymphoma. 61(9). 2122–2128. 13 indexed citations
9.
Cencini, Emanuele, et al.. (2020). Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia. Blood Coagulation & Fibrinolysis. 31(6). 416–418. 4 indexed citations
10.
Gozzetti, Alessandro, Anna Sicuranza, Elisabetta Zappone, et al.. (2020). Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients. Frontiers in Oncology. 10. 570187–570187. 12 indexed citations
11.
Granai, Massimo, Teresa Amato, Arianna Di Napoli, et al.. (2019). IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 477(1). 143–150. 2 indexed citations
12.
Cencini, Emanuele, Alberto Fabbri, Francesco Lauria, & Monica Bocchia. (2018). Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review. Annals of Hematology. 97(5). 821–829. 4 indexed citations
13.
Cattaneo, Francesca, Emanuele Cencini, Alessandro Gozzetti, et al.. (2017). Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia. Blood. 130(18). 2006–2017. 20 indexed citations
14.
Cencini, Emanuele, et al.. (2017). Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large b-cell lymphoma.. Mediterranean Journal of Hematology and Infectious Diseases. 9(1). e2017040–e2017040. 2 indexed citations
15.
Lauria, Francesco, Emanuele Cencini, & Francesco Forconi. (2011). Alternative methods of cladribine administration. Leukemia & lymphoma. 52(sup2). 34–37. 14 indexed citations
16.
Rinaldi, Andrea, Michael Mian, Ivo Kwee, et al.. (2011). Genome‐wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia. British Journal of Haematology. 154(5). 590–599. 25 indexed citations
17.
Forconi, Francesco, Emanuele Cencini, Elisa Sozzi, et al.. (2011). Insight into the behavior of hairy cell leukemia by immunogenetic analysis. Leukemia & lymphoma. 52(sup2). 103–107. 3 indexed citations
18.
Rasi, Silvia, Valeria Spina, Alessio Bruscaggin, et al.. (2010). A variant of theLRP4gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome. British Journal of Haematology. 152(3). 284–294. 29 indexed citations
19.
Sozzi, Elisa, Teresa Amato, Surinder S. Sahota, et al.. (2010). Lack of allelic exclusion by secondary rearrangements of tumour B‐cell receptor light chains in hairy cell leukaemia. Hematological Oncology. 29(1). 31–37. 8 indexed citations
20.
Rossi, Davide, Elisa Sozzi, Lorenzo De Paoli, et al.. (2009). The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. British Journal of Haematology. 146(1). 64–75. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026